Identity & Authority: Vafseo (Akebia Therapeutics, Inc.) – Signal Evidence & AI Readability

Vafseo (Akebia Therapeutics, Inc.)

(https://vafseo.com) 📸 Data Snapshot: May 26, 2026
Identity & Authority — The Lens

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Identity & Authority Expert verifiability & Schema depth.
10 Impact Weight: 15 / 100
67% Reputation

The primary authority gap is technical: the schema_json is null, indicating a lack of structured data to define the Organization or the drug’s technical properties to search engines. While the brand Akebia Therapeutics is named, there is no Person schema for medical directors or lead researchers, which is a missed opportunity for establishing individual expert authority beyond the corporate entity.

There is no disconnect between marketing tone and demonstrated reality. In fact, the marketing tone is heavily suppressed by regulatory requirements, with nearly 60% of the text dedicated to adverse effects, contraindications, and risks (death, heart attack, stroke). This ‘reverse-BS’ pattern is typical of highly regulated pharmaceutical products where the risk disclosure outweighs the benefit claim in character count.

Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.

🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage — no schema detected (entity gap)
🛡️ Trust Signals — external proof links that back the declared identity
0Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 0 0
Explore the other reputation pillars for Vafseo (Akebia Therapeutics, Inc.)